The Pitt Street Research valuation range for PSC from 5 November 2019 was at A$0.44 per share base case and A$0.93 per share optimistic case, including all the risks, like Arcadia project beeing in Zimbabwe...
"... A steady growth in lithium prices, further progress on the Arcadia development plan and clarity on project funding will help drive favourable sentiment and re-rate the stock into our valuation range..."
Since our NPV is increased by 39%, their new valuation range would be from A$0.61 to A$1.29.
I think we will get to this range as soon as PSC announces the US$162 Mio. funding path, be it with a mix of debt/equity with an African Development Bank, Uranium One...
This is my personal opinion only and it is not financial advice. Do your own research.
The Pitt Street Research valuation range for PSC from 5 November...
Add PSC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.005(3.13%) |
Mkt cap ! $78.98M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 15.5¢ | $61.19K | 373.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 60000 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 11933 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| PSC (ASX) Chart |